TrialThe Lancet. Respiratory medicine2021

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial.

Arvinder S Soin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.